Blood Blister Management in Anticoagulated Patients

Initial Assessment and Classification

The American College of Cardiology recommends determining if a bleed is major by checking for criteria such as bleeding at a critical site, hemodynamic instability, or a significant decrease in hemoglobin, to classify a blood blister as a non-major bleed 1, 2
A blood blister does not meet the criteria for a major bleed, which includes bleeding at critical sites, hemodynamic instability, or a hemoglobin decrease ≥2 g/dL, and is thus considered a non-major bleed 1, 2

The American College of Cardiology suggests continuing oral anticoagulation therapy without interruption for a blood blister, as the thrombotic risk of stopping anticoagulation outweighs the bleeding risk 1, 2, 3
Apply local therapy with manual compression for 3-5 minutes directly to the blister site, and consider a non-adherent dressing after achieving hemostasis 1, 2, 3

The American College of Cardiology recommends assessing the risks and benefits of continuing concomitant antiplatelet therapy, but not routinely stopping either medication for a blood blister 1, 2, 3
Assess for and manage comorbidities that could contribute to bleeding, such as thrombocytopenia, uremia, liver disease, or supratherapeutic anticoagulation levels 1, 2

The American College of Cardiology suggests only temporarily holding anticoagulation if the blister becomes infected and requires surgical intervention, multiple blood blisters develop, or the patient develops signs of major bleeding from another source 1, 2, 3

For patients with hemophilia or other bleeding disorders, the Centers for Disease Control and Prevention recommends managing a blood blister with local compression using a fine needle if drainage is needed, followed by firm pressure for >2 minutes 5
The American College of Cardiology states that the management approach is identical regardless of anticoagulant type for non-major bleeding like blood blisters—continue the medication and apply local therapy 1, 2

The American College of Cardiology advises against routinely administering vitamin K, prothrombin complex concentrates, or DOAC reversal agents for a blood blister, as these are reserved for major bleeding only 1, 2, 3
The American College of Cardiology recommends against routinely transfusing platelets in patients on antiplatelet therapy with a blood blister, as this has not been shown to improve outcomes and may cause harm 3